ArticleInternational journal of molecular sciences2021

The Benefits and Hazards of Intravitreal Mesenchymal Stem Cell (MSC) Based-Therapies in the Experimental Ischemic Optic Neuropathy.

Yao-Tseng Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.